- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 40.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 40.56M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.86M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $31.12M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.83M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $27.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $28.3M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.48M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $18.97M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $40.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $42.62M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $37.86M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $36.62M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $101.36M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $101.3M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $81.99M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.22M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.32M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.07M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.7M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.63M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.55M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $838.4K |
| Revenue | Q1 2026 · Mar 31, 2026 | $9.34M |
| Revenue | Q1 2026 · Mar 31, 2025 | $644.6K |